Lucrative Opportunities in North America to Propel the Growth of the Scleroderma Diagnostics and Therapeutics Market 2017 – 2024The Scleroderma Diagnostics and Therapeutics market intelligence report from TMR is a valuable tool that enables vendors to identify growth avenues, and strategize for launch of products and services. The analysis and research team at TMR enables customization of Scleroderma Diagnostics and Therapeutics market report for any market study. Based on type, the genetic testing services market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing, and others. Genetic Testing Services Market: Geographical and Competitive DynamicsGeographically, the global genetic testing services has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global genetic testing services market has been segmented as follows:Global Genetic Testing Services Market, by Test TypePrenatal TestingNewborn ScreeningPredictive & Presymptomatic TestingPharmacogenomic TestingOthersGlobal Genetic Testing Services Market, by Service ProviderHospital-based LaboratoriesDiagnostic laboratoriesSpecialty ClinicsOthersGlobal Genetic Testing Services Market, by ApplicationOncologyInfectious DiseasesAutoimmune DiseasesOthersGlobal Genetic Testing Services Market, by GeographyNorth America U.S. CanadaEurope Germany U.K. France Spain Italy Rest of EuropeAsia Pacific China Japan India Australia & New Zealand Rest of APACLatin America Brazil Mexico Rest of LATAMMiddle East & Africa GCC South Africa Israel Rest of MEA.

Source: The North Africa Journal February 12, 2020 20:22 UTC